Drug Trial Radar · NCT07835295
REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
316
Planned (sponsor's estimate)
Start
Sep 2026
Primary completion
Sep 2028
Study completion Jan 2029
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to compare four commonly used anesthesia medication strategies for placing a breathing tube in patients undergoing spine surgery that requires motor evoked potential (MEP) monitoring.
Conditions
- Airway Management
- Endotracheal Intubation
Interventions
Low-Dose RemifentanilDrug
Remifentanil 2 mcg/kg intravenous bolus
High-Dose RemifentanilDrug
Remifentanil 4 mcg/kg intravenous bolus
SuccinylcholineDrug
Succinylcholine 1 mg/kg intravenous bolus
RocuroniumDrug
Rocuronium 0.6 mg/kg intravenous bolus
SugammadexDrug
Sugammadex reversal after intubation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Clinically Acceptable Intubating ConditionsTime frame: During the first endotracheal intubation attempt after study drug administration, assessed within approximately 10 minutes after induction of anesthesia
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Jacksonville, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.